Saw a list of the leron clinical trials expected to be completed within the next 9 months on a Facebook Cytodyn Shareholders Community group post. While a repeat look for most, it sure made me smile (and feel much better prepared to face the Monday morning brokerage account blues).

Below is the Clinical Trials.com URL to see the full list:

Clinical Trials.com Search with Leronlimab

(Credit- and my thanks- to a poster on yahoo)
___________________________________

According to clinicaltrials.gov, within the next 9 months there are 7 clinical studies expected to be completed.


Actual Enrollment : 56 participants
Official Title: A Phase 2, Randomized, Double Blind, Placebo Controlled Study to Evaluate the Efficacy and Safety of Leronlimab in Patients Experiencing Prolonged Coronavirus Disease 2019 (COVID-19) Symptoms [Long-Haulers]
Estimated Study Completion Date : July 23, 2021
https://www.clinicaltrials.gov/ct2/show/study/NCT04678830...
____________________

Estimated Enrollment : 394 participants
Official Title: A Phase 2b/3, Randomized, Double Blind, Placebo Controlled, Adaptive Design Study to Evaluate the Efficacy and Safety of Leronlimab for Patients With Severe or Critical Coronavirus Disease 2019 (COVID-19)
Estimated Study Completion Date : October 15, 2021
https://www.clinicaltrials.gov/ct2/show/study/NCT04347239...
_____________________

Estimated Enrollment : 30 participants
Official Title: Basket Study of Leronlimab (PRO 140) in Patients With CCR5+ Locally Advanced or Metastatic Solid Tumors
Estimated Study Completion Date : December 2021
https://www.clinicaltrials.gov/ct2/show/study/NCT04504942...
_____________________


Estimated Enrollment 306 participants
Official Title: A Phase 3, Randomized, Double Blind, Placebo Controlled Trial to Evaluate the Efficacy and Safety of Leronlimab in Combination With Standard of Care for Critically Ill Patients With Coronavirus Disease 2019 (COVID-19) With Need for Mechanical Ventilation or Extracorporeal Membrane Oxygenation
Estimated Study Completion Date : December 2021
https://www.clinicaltrials.gov/ct2/show/study/NCT04901689...
_____________________


Estimated Enrollment : 594 participants
Official Title: A Phase 3, Randomized, Double Blind, Placebo Controlled Trial to Evaluate the Efficacy and Safety of Leronlimab in Combination With Standard of Care for Moderately Ill Patients With Coronavirus Disease 2019 (COVID-19) Pneumonia
Estimated Study Completion Date : February 2022
https://www.clinicaltrials.gov/ct2/show/study/NCT04901676...
_____________________


Estimated Enrollment : 60 participants
Official Title: A Phase II, Multi-center, Randomized, Double-Blind, Placebo-Controlled, Two-Arm Study of the Safety and Efficacy of Leronlimab (PRO 140) in Adult Patients With Nonalcoholic Steatohepatitis (NASH)
Estimated Study Completion Date : March 22, 2022
https://www.clinicaltrials.gov/ct2/show/study/NCT04521114...
_____________________


Estimated Enrollment : 48 participants
Official Title: A Phase Ib/II Study of Leronlimab (PRO 140) Combined With Carboplatin in Patients With CCR5+ Metastatic Triple Negative Breast Cancer (mTNBC)
Estimated Study Completion Date : March 2022
https://www.clinicaltrials.gov/ct2/show/study/NCT03838367...